Jacob Subash, MD
Dermatology · Cary, NCNPI 1417451824
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 29.6% of the total. 2025 is the largest year on record at $963, more than ten times the $81 reported in 2021. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.
Across 126 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734
- Pfizer$238
- Novartis$231
- Galderma Laboratories, L.p.$176
- Sun Pharmaceutical Industries Inc.$170
- E.r. Squibb & Sons, L.L.C.$167
- plus $761 from 7 others
What the payments were for
- Food & beverage$2,32794%
- Education$1496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $734 |
| Pfizer | 8 | $238 |
| Novartis | 13 | $231 |
| Galderma Laboratories, L.p. | 19 | $176 |
| Sun Pharmaceutical Industries Inc. | 8 | $170 |
| E.r. Squibb & Sons, L.L.C. | 8 | $167 |
| Amgen | 4 | $164 |
| Johnson & Johnson | 6 | $158 |
| Incyte Corporation | 5 | $129 |
| Arcutis Biotherapeutics, Inc. | 7 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Botanix SB Inc | 2 | $38 |
How this compares
$2,476 in reported general payments places this provider in the 50th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 84 | $5,886 |
| Clobetasol Propionate | 98 | $3,621 |
| Tacrolimus | 13 | $2,609 |
| Ketoconazole | 64 | $1,514 |
| Triamcinolone Acetonide | 80 | $774 |
| Halobetasol Propionate | 11 | $743 |
| Desonide | 16 | $690 |
| Fluocinonide | 18 | $622 |
| Clindamycin Phosphate | 22 | $585 |
| Metronidazole | 17 | $554 |
| Terbinafine Hcl | 22 | $550 |
| Doxycycline Hyclate | 41 | $442 |
| Mupirocin | 48 | $333 |
| Hydrocortisone | 62 | $284 |
| Nystatin | 18 | $212 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cary
- John SoderbergCary$398K
- Catherine HrenCary$29K
- Heidi MangelsdorfCary$12K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.